Vanderbilt-Ingram Cancer Center: Breast Neoplasms trials

The registry lists 38 Breast Neoplasms studies with Vanderbilt-Ingram Cancer Center as lead sponsor. 2 are open to participants now and 15 have results posted.

Early Phase 1 2Phase 1 11Phase 2 14No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyRecruitingNCT06828588Early Phase 1
• Collecting and Storing Tissue Samples From Women With or Without Breast CancerRecruitingNCT00899301
• Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast CancerTerminatedNCT03566485Phase 1/2Results posted
• Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast CancerCompletedNCT03238196Phase 1Results posted
• Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast CancerCompletedNCT03206203Phase 2Results posted
• Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast CancerTerminatedNCT02457910Phase 1/2Results posted
• GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast CancerTerminatedNCT01918306Phase 1/2Results posted
• PET/CT Evaluation of Treatment Response in Breast CancerTerminatedNCT01222416Not applicableResults posted
• Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerTerminatedNCT01205685Phase 2Results posted
• Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT01031446Phase 1/2Results posted
• Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00984490Not applicableResults posted
• Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast CancerCompletedNCT00930930Phase 2Results posted
• Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by SurgeryCompletedNCT00633750Phase 2Results posted
• Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.TerminatedNCT00611715Phase 2Results posted
• Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast CancerCompletedNCT00574145Not applicableResults posted
• PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORETerminatedNCT00499681Phase 2Results posted
• Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerTerminatedNCT00343512Phase 2Results posted
• Improving Care After Inherited Cancer TestingActive, not recruitingNCT04763915Not applicable
• Hatha Yoga in Breast Cancer SurvivorsTerminatedNCT02923037Not applicable
• Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast CancerCompletedNCT02672475Phase 1
• Ultra High Field MRI and MRS Techniques in Diagnosing Breast CancerTerminatedNCT01938651Not applicable
• BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast CancerCompletedNCT01791478Phase 1
• PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast CancerCompletedNCT01248494Phase 1
• Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast CancerWithdrawnNCT01240941Phase 2
• MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast CancerWithdrawnNCT01240928Phase 1
• Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorTerminatedNCT01096381
• Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast CancerWithdrawnNCT01013506Phase 2
• Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerCompletedNCT00897793
• Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast CancerCompletedNCT00897468
• Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00680758Phase 1
• Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and ProteomicsCompletedNCT00656604Not applicable
• Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryTerminatedNCT00651976Early Phase 1
• T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
• Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00647218Not applicable
• Erlotinib and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00574366Phase 1
• Family Quality of Life Among Families With a Member Who is a Cancer PatientCompletedNCT00544336
• Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy ParticipantsCompletedNCT00474604Not applicable
• Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00006104Phase 2